{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:50:31Z","timestamp":1735584631831},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007431","name":"NRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007431","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea government","award":["NRF-2019M3E5D4065860"]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"Abstract<\/jats:title>\n \n Motivation<\/jats:title>\n Blockade of the human ether-\u00e0-go-go-related gene (hERG) channel by small compounds causes a prolonged QT interval that can lead to severe cardiotoxicity and is a major cause of the many failures in drug development. Thus, evaluating the hERG-blocking activity of small compounds is important for successful drug development. To this end, various computational prediction tools have been developed, but their prediction performances in terms of sensitivity and negative predictive value (NPV) need to be improved to reduce false negative predictions.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n We propose a computational framework, DeepHIT, which predicts hERG blockers and non-blockers for input compounds. For the development of DeepHIT, we generated a large-scale gold-standard dataset, which includes 6632 hERG blockers and 7808 hERG non-blockers. DeepHIT is designed to contain three deep learning models to improve sensitivity and NPV, which, in turn, produce fewer false negative predictions. DeepHIT outperforms currently available tools in terms of accuracy (0.773), MCC (0.476), sensitivity (0.833) and NPV (0.643) on an external test dataset. We also developed an in silico chemical transformation module that generates virtual compounds from a seed compound, based on the known chemical transformation patterns. As a proof-of-concept study, we identified novel urotensin II receptor (UT) antagonists without hERG-blocking activity derived from a seed compound of a previously reported UT antagonist (KR-36676) with a strong hERG-blocking activity. In summary, DeepHIT will serve as a useful tool to predict hERG-induced cardiotoxicity of small compounds in the early stages of drug discovery and development.<\/jats:p>\n <\/jats:sec>\n \n Availability and implementation<\/jats:title>\n https:\/\/bitbucket.org\/krictai\/deephit and https:\/\/bitbucket.org\/krictai\/chemtrans<\/jats:p>\n <\/jats:sec>\n \n Supplementary information<\/jats:title>\n Supplementary data are available at Bioinformatics online.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btaa075","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T12:15:54Z","timestamp":1580300154000},"page":"3049-3055","source":"Crossref","is-referenced-by-count":71,"title":["DeepHIT: a deep learning framework for prediction of hERG-induced cardiotoxicity"],"prefix":"10.1093","volume":"36","author":[{"given":"Jae Yong","family":"Ryu","sequence":"first","affiliation":[{"name":"Information-based Drug Research Center , Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea"}]},{"given":"Mi Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Information-based Drug Research Center , Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea"}]},{"given":"Jeong Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Information-based Drug Research Center , Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea"}]},{"given":"Byung Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Information-based Drug Research Center , Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea"}]},{"ORCID":"http:\/\/orcid.org\/0000-0002-4242-0818","authenticated-orcid":false,"given":"Kwang-Seok","family":"Oh","sequence":"additional","affiliation":[{"name":"Information-based Drug Research Center , Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea"},{"name":"Department of Medicinal and Pharmaceutical Chemistry , University of Science and Technology, 34129 Daejeon, Republic of Korea"}]}],"member":"286","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"2023013111510327500_btaa075-B1"},{"key":"2023013111510327500_btaa075-B2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1476-5381.2010.00889.x","article-title":"GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo","volume":"161","author":"Behm","year":"2010","journal-title":"Br. J. Pharmacol"},{"key":"2023013111510327500_btaa075-B3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/minf.201500040","article-title":"Pred-hERG: a novel web-accessible computational tool for predicting cardiac toxicity","volume":"34","author":"Braga","year":"2015","journal-title":"Mol. Inform"},{"key":"2023013111510327500_btaa075-B4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/acs.jcim.8b00769","article-title":"Deep learning-based prediction of drug-induced cardiotoxicity","volume":"59","author":"Cai","year":"2019","journal-title":"J. Chem. Inf. Model"},{"key":"2023013111510327500_btaa075-B5","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1021\/jm0208875","article-title":"Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers","volume":"45","author":"Cavalli","year":"2002","journal-title":"J. Med. Chem"},{"key":"2023013111510327500_btaa075-B6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"2023013111510327500_btaa075-B7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0091270006286436","article-title":"Clinical evaluation of QT\/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline","volume":"46","author":"Darpo","year":"2006","journal-title":"J. Clin. Pharmacol"},{"key":"2023013111510327500_btaa075-B8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10822-016-9986-0","article-title":"Compilation and physicochemical classification analysis of a diverse hERG inhibition database","volume":"30","author":"Didziapetris","year":"2016","journal-title":"J. Comput. Aided Mol. Des"},{"key":"2023013111510327500_btaa075-B9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/cmdc.201000024","article-title":"Prospective validation of a comprehensive in silico hERG model and its applications to commercial compound and drug databases","volume":"5","author":"Doddareddy","year":"2010","journal-title":"ChemMedChem"},{"key":"2023013111510327500_btaa075-B10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13321-018-0270-2","article-title":"PyBioMed: a python library for various molecular representations of chemicals, proteins and DNAs and their interactions","volume":"10","author":"Dong","year":"2018","journal-title":"J. Cheminform"},{"key":"2023013111510327500_btaa075-B11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/jpet.301.2.427","article-title":"Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel","volume":"301","author":"Ekins","year":"2002","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"2023013111510327500_btaa075-B12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-2946-1-8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J. Cheminform"},{"key":"2023013111510327500_btaa075-B13","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2023013111510327500_btaa075-B14","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2023013111510327500_btaa075-B15"},{"key":"2023013111510327500_btaa075-B16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"key":"2023013111510327500_btaa075-B17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.intimp.2016.09.002","article-title":"A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension","volume":"40","author":"Lee","year":"2016","journal-title":"Int. Immunopharmacol"},{"key":"2023013111510327500_btaa075-B18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12859-019-2814-5","article-title":"Computational determination of hERG-related cardiotoxicity of drug candidates","volume":"20","author":"Lee","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"2023013111510327500_btaa075-B19","doi-asserted-by":"crossref","first-page":"1700074","DOI":"10.1002\/minf.201700074","article-title":"Modeling of the hERG K+ channel blockage using online chemical database and modeling environment (OCHEM","volume":"36","author":"Li","year":"2017","journal-title":"Mol. Inform"},{"key":"2023013111510327500_btaa075-B20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","article-title":"Mordred: a molecular descriptor calculator","volume":"10","author":"Moriwaki","year":"2018","journal-title":"J. Cheminform"},{"key":"2023013111510327500_btaa075-B21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3389\/fphar.2018.01035","article-title":"Experimentally validated pharmacoinformatics approach to predict hERG inhibition potential of new chemical entities","volume":"9","author":"Munawar","year":"2018","journal-title":"Front. Pharmacol"},{"key":"2023013111510327500_btaa075-B22","article-title":"Rectified linear units improve restricted Boltzmann machines","author":"Nair","year":"2010","journal-title":"In: Proceedings of the 27th International Conferenceon Machine Learning (ICML-10), Haifa, Israel, pp. 807\u2013814."},{"key":"2023013111510327500_btaa075-B23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2017.02.003","article-title":"A novel urotensin II receptor antagonist, KR-36996, improved cardiac function and attenuated cardiac hypertrophy in experimental heart failure","volume":"799","author":"Oh","year":"2017","journal-title":"Eur. J. Pharmacol"},{"key":"2023013111510327500_btaa075-B24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxlet.2012.10.018","article-title":"Predicted drug-induced bradycardia related cardio toxicity using a zebrafish in vivo model is highly correlated with results from in vitro tests","volume":"216","author":"Park","year":"2013","journal-title":"Toxicol. Lett"},{"key":"2023013111510327500_btaa075-B25","first-page":"2825","article-title":"Scikit-learn: machine learning in python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res"},{"key":"2023013111510327500_btaa075-B26","first-page":"2960","author":"Pereira","year":"2012"},{"key":"2023013111510327500_btaa075-B27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4161\/chan.2.2.6004","article-title":"Role of hERG potassium channel assays in drug development","volume":"2","author":"Priest","year":"2008","journal-title":"Channels (Austin)"},{"key":"2023013111510327500_btaa075-B28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res"},{"key":"2023013111510327500_btaa075-B29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J. Chem. Inf. Model"},{"key":"2023013111510327500_btaa075-B30","author":"Ryu","year":"2018"},{"key":"2023013111510327500_btaa075-B31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"2023013111510327500_btaa075-B32","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1016\/j.bmc.2008.01.017","article-title":"A binary QSAR model for classification of hERG potassium channel blockers","volume":"16","author":"Thai","year":"2008","journal-title":"Bioorg. Med. Chem"},{"key":"2023013111510327500_btaa075-B33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2015.03.003","article-title":"Computational investigations of hERG channel blockers: new insights and current predictive models","volume":"86","author":"Villoutreix","year":"2015","journal-title":"Adv. Drug Deliv. Rev"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btaa075\/32648924\/btaa075.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/36\/10\/3049\/48990556\/bioinformatics_36_10_3049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/36\/10\/3049\/48990556\/bioinformatics_36_10_3049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T20:57:34Z","timestamp":1675198654000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/36\/10\/3049\/5727757"}},"subtitle":[],"editor":[{"given":"Arne","family":"Elofsson","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2020,2,5]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btaa075","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5,15]]},"published":{"date-parts":[[2020,2,5]]}}}